Subcellular localization is emerging as an important mechanism for mTORC1 regulation. We report that the tuberous sclerosis complex (TSC) signalling node, TSC1, TSC2 and Rheb, localizes to peroxisomes, where it regulates mTORC1 in response to reactive oxygen species (ROS). TSC1 and TSC2 were bound by peroxisomal biogenesis factors 19 and 5 (PEX19 and PEX5), respectively, and peroxisome-localized TSC functioned as a Rheb GTPase-activating protein (GAP) to suppress mTORC1 and induce autophagy. Naturally occurring pathogenic mutations in TSC2 decreased PEX5 binding, and abrogated peroxisome localization, Rheb GAP activity and suppression of mTORC1 by ROS. Cells lacking peroxisomes were deficient in mTORC1 repression by ROS, and peroxisome-localization-deficient TSC2 mutants caused polarity defects and formation of multiple axons in neurons. These data identify a role for the TSC in responding to ROS at the peroxisome, and identify the peroxisome as a signalling organelle involved in regulation of mTORC1.
of the specific subcellular compartment(s) in which the TSC tumour suppressor functions to regulate mTORC1 in response to ROS has heretofore remained elusive.
Peroxisomes carry out key metabolic functions in the cell including β-oxidation of fatty acids, and are a major source of cellular ROS (refs 20,21) . Like mitochondria, peroxisomes are autonomously replicating organelles. Peroxisome biogenesis requires peroxin (PEX) proteins, which are essential for assembly of functional peroxisomes 22 . Specific PEX proteins, such as PEX5, function as import receptors that recognize peroxisome-targeting signals (PTSs) in proteins to target them to the peroxisome 22 .
Here we show that TSC1 and TSC2 associate with PEX proteins and are localized to peroxisomal membranes, where they regulate mTORC1 signalling in response to ROS. Activation of TSC2 and repression of mTORC1 by peroxisomal ROS induces autophagy, and in cells lacking peroxisomes, TSC2 is unable to repress mTORC1 in response to ROS. Disease-associated point mutations in the TSC2 gene result in loss Supplementary Fig. S6 . Source data for the statistical analysis are shown in Supplementary Table S1 .
of PEX5 binding, and abrogate peroxisomal localization, TSC2 GAP activity for Rheb, and ROS-induced repression of mTORC1. Our data reveal a previously unknown role for the peroxisome as a signalling organelle involved in regulation of mTORC1 by TSC, and suggest that this TSC signalling node functions as a cellular sensor for ROS to regulate mTORC1 and autophagy.
RESULTS

The TSC tumour suppressor localizes to peroxisomes
In rat liver (FAO) cells, endogenous TSC1, TSC2 and Rheb localized to discrete vesicular structures, most of which co-localized with the peroxisomal marker, peroxisomal membrane protein 70 (PMP70; Fig. 1a ). Quantitative analysis of these images revealed a correlation between TSC and PMP70 co-localization when compared with the lysosomal marker LAMP1 (lysosome-associated membrane protein 1; Fig. 1b ). As expected, TSC1 and TSC2 also co-localized with each other in discrete vesicular structures ( Fig. 1c ). Endogenous TSC2 co-localization with Rheb (which also co-localized with PMP70) was also observed (Fig. 1a, bottom panels) . Controls demonstrated the absence of co-localization with markers for other cellular organelles including mitochondria (mitochondrial cox 2, MTCO2) and endosomes (early endosome antigen 1, EEA1; Supplementary  Fig. S1a ). Specificity for the antibody used to detect endogenous TSC2 was confirmed using short interfering RNA (siRNA) knockdown of TSC2 ( Fig. 1d-f ), and TSC2-deficient mouse embryonic fibroblasts (MEFs; Supplementary Fig. S1b ). Cell fractionation confirmed the TSC signalling node (endogenous TSC1, TSC2 and Rheb) in the peroxisome fraction, which contained negligible amounts of other organelles ( Fig. 2a,b ). Loss of TSC2 (but not TSC1 or Rheb) from the peroxisome fraction was observed in TSC2 −/− MEFs (Fig. 2c ). TBC1D7 (a third subunit of the TSC1-TSC2 complex 23 ) was also found in the peroxisome fraction ( Fig. 2a and Supplementary Fig. S1c ), whereas AKT was detected in cytosolic (primarily) compartments ( Fig. 2a-c and Supplementary  Fig. S1c,d ). Endogenous TSC2 was detected in both the membrane and cytosolic fractions ( Fig. 2a,b and Supplementary Fig. S1c,d) , consistent with what is known about membrane localization of active, and cytosolic sequestration of inactive, forms of this tumour suppressor, respectively [24] [25] [26] . Peroxisome localization of the TSC signalling node was also observed in HEK293 ( Supplementary  Fig. S1c ) and HeLa ( Supplementary Fig. S1d ) cells, confirming the generalizability to other cell types.
The TSC tumour suppressor is on the cytosolic surface of the peroxisome TSC2 tumour suppressor activity occurs through membrane dissociation and cytosolic binding of this tumour suppressor by 14-3-3 proteins, sequestering it away from its activation partner TSC1 and its GAP target Rheb 24 . In MCF-7 cells expressing constitutively active myristoylated AKT (myr-AKT), AKT phosphorylation inactivates TSC2, with loss of TSC2 from the membrane and peroxisomal fractions and increased TSC2 in the cytosol (Fig. 3a ). As predicted, TSC2 was released from peroxisome and membrane compartments into the cytosol with mitogenic stimulation by insulin ( Fig. 3b ). Furthermore, TSC2 phosphorylated by AKT at Ser 939 was abundant in the cytosolic, but absent or barely detectable in the peroxisomal fraction of cells ( Fig. 3c ).
Correlative data that TSC2 resided at the peroxisomal membrane were supported with direct evidence from a protease protection assay, where peroxisomes were proteinase K treated in the absence or presence of membrane-disrupting detergent (Triton X-100). The peroxisomal membrane protein PMP70 and TSC1, TSC2 and Rheb were degraded in both the absence and presence of detergent, indicating that they were membrane-associated ( Fig. 3d ), whereas catalase, a matrix protein control, was resistant to proteinase K, confirming the TSC signalling node resides in peroxisomal membranes (Fig. 3d ).
The TSC signalling node functions at the peroxisome to induce autophagy in response to ROS
As a major site of ROS generation, we reasoned that TSC at the peroxisome might induce autophagy, which is regulated by both mTORC1 (refs 6-8,11) and ROS (refs 27, 28) . Consistent with this hypothesis, overexpression of both Flag-TSC1 and Flag-TSC2 increased autophagosome formation relative to overexpression of either Flag-TSC1 or Flag-TSC2 alone (Fig. 4a,b ). In these cells, exogenous ROS (H 2 O 2 ) induced rapid (<1 h) suppression of mTORC1, decreased p62 by 24 h, and increased the ratio of LC3 II/actin ( Supplementary Fig. S2a,b ). The decrease in p62 was significantly inhibited by bafilomycin A1 (Baf A1), as was the increase in LC3 II ( Supplementary Fig. S2c,d) . Similarly, as shown in Supplementary Fig. S2e , decreased p62 in response to H 2 O 2 occurred only in autophagy-proficient (ATG5 +/+ MEFs) but not in autophagy-deficient cells 29 (ATG5 −/− MEFs). Finally, increased autophagic flux in response to H 2 O 2 was also demonstrated by accelerated degradation of GFP-LC3 relative to RFP-LC3 (refs 9,10), which is less stable in the acidic pH of the autolysosomes (Fig. 4c,d) , confirming the ability of TSC to respond to ROS to regulate autophagy.
Drugs such as fibrates (for example, Wy-14643) activate peroxisome proliferator-activated receptor alpha (PPAR-alpha), to induce peroxisome proliferation in rodent liver cells 30, 31 , and increase levels of peroxisomal ROS (ref. 20) . FAO cells were treated with Wy-14643, which induced the expected increase in the PPAR-alphainducible proteins peroxisomal bifunctional enzyme (EHHADH) and peroxisomal thiolase (ACAA1; Fig. 4e ), and increased superoxide radical production shown by dihydroethidium (DHE) staining ( Fig. 4f ). Fibrate-induced ROS suppressed mTORC1 ( Fig. 4e ), to induce autophagy, as confirmed by increased LC3 puncta and electron microscopy ( Fig. 4g -i). Peroxisome biogenesis disorders (PBDs) are caused by genetic defects in key proteins that participate in this process 21, 32 , with Zellweger syndrome being the most severe 32 . PBD-associated disease mutations result in an absence of functional peroxisomes. Co-localization with PMP70 for TSC2 and Rheb was lost in peroxisome-deficient human Zellweger cells ( Fig. 5a ). These cells are deficient in PEX5-mediated protein import but can still assemble peroxisomal membrane proteins, accounting for the occasional PMP-positive puncta, which interestingly also show co-localization with TSC1 ( Fig. 5a ). Peroxisome-deficient Zellweger (untransformed GM13267) cells were deficient in mTORC1 repression in response to H 2 O 2 relative to control peroxisome-proficient (untransformed GM15871) cells ( Fig. 5b ). H 2 O 2 activated ATM, AMPK and TSC2 to repress mTORC1 and induce autophagy in control fibroblasts, whereas Zellweger fibroblasts lacking peroxisomes were resistant to mTORC1 repression by H 2 O 2 (Fig. 5b) . These data were confirmed in two other control (GM13427) and Zellweger (GM13269) cell cultures ( Supplementary Fig. S3a ). As predicted 19 , in peroxisome-proficient cells, repression of mTORC1 by H 2 O 2 was rescued with N -acetyl cysteine (Fig. 5c ), and decreased p62 was inhibited by Baf A1 ( Supplementary Fig. S3b,c) .
In contrast to ROS repression of mTORC1, which is TSC2dependent, activation of mTORC1 by amino acids does not signal through TSC- Rheb 13, 15 . This predicts that Zellweger cells would still activate mTORC1 in response to stimulation with amino acids. As shown in Fig. 5d , mTORC1 signalling was activated by amino acids to an equivalent degree in both peroxisome-deficient Zellweger fibroblasts (GM13267) and control peroxisome-proficient fibroblasts (GM15871), which was confirmed in two other control (GM13427) and Zellweger (GM13269) cell ( Supplementary Fig. S3d ).
TSC1 and TSC2 bind peroxins PEX19 and PEX5
PEX proteins mediate localization of peroxisomal proteins and enzymes. We observed by co-immunoprecipitation of both endogenous and Flag-tagged proteins that TSC2 was bound by PEX5 ( Fig. 6a,d ). PEX5 is known to import proteins into the peroxisomal matrix 22 , whereas TSC2 localizes to endomembranes (our data and ref. 33); therefore further experiments were performed to confirm that TSC2 was a bona fide target for the PEX5 import receptor.
In silico analysis of the TSC2 (http://peroxisomedb.org; ref. 34 ) identified a region of homology with known PTS1 sequences. This ARL motif 1739 KWIARLRHIKR 1749 was located 63 amino acids from the carboxy terminus of TSC2 protein (Fig. 6b ). Although most PEX5 targets identified so far contain a PTS1 at their extreme C terminus 22 , Supplementary Fig. S6 . Source data for the statistical analysis are shown in Supplementary Table S1 .
internal sequences may mediate some peroxisomal targeting [35] [36] [37] .
To demonstrate that this ARL sequence functioned as a PTS1, we substituted the ARL sequence for an SKL PTS1 motif in a DsRed-SKL fusion protein that localizes to the peroxisome. The DsRed-ARL fusion protein co-localized with a GFP fusion protein containing the SKL PTS1, and peroxisome marker PMP70 and catalase ( Fig. 6c ), whereas deletion of the inserted ARL sequence in this DsRed fusion protein (DsRed-Del-ARL) resulted in loss of cytoplasmic staining ( Fig. 6c ,
Amino acids b c top panel), indicating that a C-terminal ARL motif was capable of targeting proteins to the peroxisome in mammalian cells. Importantly, several pathogenic TSC2 mutations were identified in this ARL site (Table 1) . To determine whether TSC2 localization to the peroxisome was impaired by these mutations, we introduced three naturally occurring mutations into a wild-type (WT) TSC2 expression construct at amino acid position 1,743, R1743Q (RQ), R1743G (RG) and R1743W (RW; (g) Subcellular fractionation of TSC2 −/− MEFs transfected with Flag-TSC2 wild type, or Flag-TSC2 mutants (RQ or RQ-9NT). β-integrin and catalase were used as subcellular markers for membrane and peroxisome fractions, respectively. WCE, whole-cell extract. The arrow indicates the position of overexpressed Flag-TSC2. (h) HEK293 cells co-transfected with Flag-TSC1 and Flag-TSC2 wild type (WT) or Flag-TSC2 G294E mutant (TSC2 mutant that cannot bind TSC1). Lysates were immunoprecipitated using anti-PEX19 and blotted for PEX19 and Flag. (i) Representative blots from subcellular fractionation of HEK293 cells overexpressing wild type (WT) or mutant (CaaX mutant) Flag-Rheb. LDH, lamin A/C and catalase were used as subcellular markers for the cytoplasmic (Cp), nuclear and peroxisome fractions, respectively. Uncropped images of western blots are shown in Supplementary Fig. S6 .
TSC2 mutants reduced PEX5 import receptor association with TSC2 ( Fig. 6d ), identifying this ARL sequence as a PEX5-binding sequence (PxBS) in TSC2. Peroxisomal localization of all three PxBS mutants was greatly diminished ( Fig. 6e and Supplementary Fig. S4a) ; the PxBS TSC2 mutants co-localized with neither lysosome ( Supplementary  Fig. S4b ), nor endoplasmic reticulum (calnexin) nor mitochondria (voltage-dependent anion channel, VDAC) markers ( Supplementary  Fig. S4c ). Importantly, introduction of nine nucleotides encoding an exogenous SKL PTS1 into the TSC2-RQ mutant, just before the C-terminal stop codon (TSC2-RQ-9NT; Fig. 6b ), restored PEX5 binding to TSC2-RQ-9NT ( Fig. 6f ) and peroxisome localization of TSC2-RQ-9NT (Fig. 6g) .
Consistent with the proposed function of TSC1 as the membrane tether for TSC2 (refs 26,38) , endogenous TSC1 co-immunoprecipitated with PEX19, which localizes proteins to peroxisomal membranes, but not PEX5 (Fig. 6a) , and we identified a potential PEX19-binding site in TSC1 at the amino terminal ( 129 LTTGVLvLIt 138 ) (http://peroxisomedb. org 34 ). Whereas a very small amount of Flag-TSC2 was associated with the PEX19-TSC1 complex (Fig. 6h) , this association was abrogated with the TSC2-G294E mutant (a TSC1-binding-deficient mutant 39 ), indicating that the little TSC2 detected in this complex was probably associated with TSC1, rather than directly bound to PEX19 (Fig. 6h) .
As a control we demonstrated that mTOR (another large protein) did not co-immunoprecipitate with either PEX5 or PEX19 (Fig. 6a ). Rheb did not contain predicted PTS sequences; however, farnesylation of the C-terminal CaaX (cysteine aliphatic aliphatic any) motif has been previously shown to localize Rheb to endomembranes and be required for Rheb activation of mTORC1 (ref.
3). We found that in contrast to WT-Rheb, CaaX-defective Rheb was not detected in the peroxisomal fraction of cells ( Fig. 6i) .
TSC functions at the peroxisome to suppress mTORC1
Inactivating PEX5 using short hairpin RNA (shRNA) to inhibit delivery of TSC2 to the peroxisome increased mTORC1 signalling ( Fig. 7a ), suggesting that localization to the peroxisome played a role in TSC GAP activity for Rheb and suppression of mTORC1 signalling. Functional assays in cells expressing Flag-tagged WT-TSC2 or PxBS TSC2 mutants (RQ, RW and RG) co-transfected with Flag-TSC1, myc-Rheb and either HA-S6K ( Fig. 7b, left panel) or HA-4E-BP1 ( Fig. 7b , right panel) showed that whereas WT-TSC2 suppressed Rheb activation of mTORC1 (evidenced by decreased phosphorylation of S6K1 and 4E-BP1 and [ 32 P]-radiolabelled S6), all three pathogenic PxBS TSC2 mutants were deficient in mTORC1 repression (Fig. 7b ). Inability to suppress mTORC1 signalling was not due to inability to bind TSC1, as control experiments revealed equivalent binding to TSC1 of WT-TSC2 and mutants (RQ, RG and RW) ( Supplementary Fig. S4d ).
To determine directly whether inability to localize to the peroxisome compromised the Rheb GAP activity of PxBS mutants, we compared their GTPase activity with WT-TSC2, using immunoprecipitated TSC heterodimers against GST-Rheb preloaded with [α-32 P]GTP. In this in vitro assay, WT-TSC2 promoted the intrinsic GTPase activity of Rheb as observed by accumulation of [α-32 P]GDP-bound Rheb, whereas none of the PxBS mutants functioned as a Rheb GAP, similar to what was observed in control experiments with the TSC2 GAP domain mutant (L1624P) protein (Fig. 7c ). This suggests that TSC2 GAP activity depends on the delivery of TSC2 to the peroxisome. However, addition of the SKL PTS1 to the TSC2-RQ mutant restored significant repression of mTORC1 signalling (Fig. 7d,e and Supplementary Fig. S4e ). This was confirmed in the in vivo Rheb guanine nucleotide binding assay, which demonstrated that TSC2-RQ-9NT had regained significant Rheb GAP activity (Fig. 7f,g) , indicating that a significant proportion of loss of activity in this mutant was attributable to loss of peroxisome localization, rather than loss of intrinsic GAP activity.
Overexpression of TSC1 and TSC2 inhibits axon growth, resulting in an increased proportion of neurons with no axon, whereas loss of TSC1 and TSC2 results in an aberrant neuronal morphology with multiple axons extending out of the cell body, a phenotype dependent on hyperactivation of mTORC1 (ref. 40 ). Expression of WT-TSC2 resulted in a significant increase in the number of neurons with no axon and a significant decrease in neurons with multiple axons, compared with controls expressing GFP alone (Fig. 7h) . In comparison, all three of the PxBS TSC2 mutants when transfected with TSC1 had the opposite effect, significantly reducing the fraction of cells with no axons and increasing the number of cells with multiple axons (Fig. 7h) , providing a functional link between loss of TSC signalling at the peroxisome and the neuronal pathophysiology of TSC.
DISCUSSION
Here we describe an intimate and previously unappreciated, relationship between the TSC signalling node and the peroxisome. We found that TSC1 and TSC2 bound to PEX19 and PEX5, respectively, and an ARL sequence required for PEX5 binding and localization to peroxisomal membranes was identified. Missense mutations within the TSC2 ARL sequence are pathogenic 41, 42 , and the ability of TSC2 to suppress mTORC1 in response to ROS is abrogated by these mutations. Neuronal expression of PxBS mutant TSC2 causes the formation of multiple axons, indicating that peroxisomal TSC2 localization is crucial for proper neuronal morphology and polarity, and providing a link between aberrant TSC signalling and brain pathophysiology. This suggests a model ( Supplementary Fig. S5 ) where the TSC tumour suppressor resides on the exterior of peroxisomal membranes, in proximity to its GAP target Rheb, and where it can be negatively regulated by cytosolic kinases such as AKT and 14-3-3 binding, and activated by peroxisomal ROS to repress mTORC1 and induce autophagy.
PTS1 sequences located at the extreme C terminus of cargo proteins interact with the C-terminal region of PEX5 through the seven tetratricopeptide repeat (TPR) domains 22 . The ARL sequence in TSC2 that functions as a PEX5-binding domain is 63 amino acids internal from the C terminus. Although an ARL sequence at the C terminus can function as a PTS1 to target proteins to the peroxisome in yeast 43 , plants 44 and as we demonstrated with a DsRed-ARL fusion protein in mammalian cells, for an internal ARL to act as a true PTS1, the protein loop containing this ARL sequence must be accommodated in the wellcharacterized ring-like structure formed by the PEX5-TPR domains 36 . However, an increasing number of PEX5-dependent targets have been discovered where a PTS1 motif is not essential or even absent 36, 37 , and internal sequences that mediate PEX5 binding have been proposed 37 . For example, yeast acyl-CoA oxidase (Pox1p) interacts directly with PEX5 but does not contain any recognizable PTS1, and C-terminal deletions of Pox1p do not affect PEX5 interaction 45 .
Present dogma dictates that PEX5 cargo is delivered to the matrix of the peroxisome. We demonstrated that TSC2 is part of the PEX5 import complex, but is localized to the peroxisomal membrane facing the cytosol. We considered two possibilities to potentially explain this conundrum: TSC2 docks with TSC1 to be retained at the cytosolic membrane, abrogating import by PEX5; TSC2 is delivered into the matrix and then recycles out to the cytosolic membrane. If Supplementary  Fig. S6 . Source data for the statistical analysis are shown in Supplementary Table S1 .
the TSC2-TSC1 heterodimer is more stable than the TSC2-PEX5 complex, peroxisomal TSC1 may function as an attractor or anchor to capture TSC2 at the cytosolic peroxisomal membrane, abrogating PEX5-mediated import of TSC2 into the matrix. Alternatively, the TSC2-PEX5 complex may enter the peroxisome matrix through PEX14 peroxisomal translocation machinery and then recycle out to interact with peroxisomal membrane-localized TSC1. Such peroxisomal protein recycling is well described for PEX5 (ref. 22) , and also occurs with rotavirus VP4 protein 46, 47 . Specific localization of TSC and mTOR to several subcellular compartments has been reported, including lysosome or endosome [13] [14] [15] [16] [17] [18] 23 , cytosol 26, 48, 49 , Golgi apparatus 50 and nucleus 48, 51 . Interesting, Rheb was recently localized to mitochondrial membranes, where it was shown to regulate mitophagy 52 . Although shuttling between these compartments is likely to occur, TSC1, TSC2 and mTOR resident in these various compartments may respond to specific stimuli. For example, mTOR is localized to the late endosome or lysosome compartment by the Ragulator complex in response to amino acids 13, [16] [17] [18] , and the TSC1-TSC2-TBC1D7 Rhebulator complex has been reported to be regulated by growth factors and energy stress in lysosomes 23 . Our finding of a TSC signalling node resident in peroxisome that responds to ROS identifies a subcellular compartment in which TSC functions to repress mTORC1 and induce autophagy in response to oxidative stress. Induction of autophagy is one of many cellular responses to oxidative stress, with superoxide (which is produced by peroxisomes) being the main ROS regulating autophagy 27 . Cytoplasmic ATM, which responds to ROS to activate AMPK and TSC2 (ref. 19) , has been previously localized to peroxisomes and a putative PTS1 sequence identified at its C terminus 53 . ATM is directly activated by ROS, with the oxidized form of this kinase forming an active disulphide crosslinked dimer 54 . Localization of ATM and the TSC signalling node to the peroxisome sets up the intriguing possibility that direct activation of ATM by peroxisomal ROS is the proximal signal that engages TSC to repress mTORC1, indicating that characterization of this, and elucidation of other signalling cascades resident at the peroxisome, now merit further study.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
Cell culture and transfection. TSC2 +/+ and TSC2 −/− MEFs (gifts from D.
Kwiatkowski, Harvard Medical School, USA), ATG5 +/+ and ATG5 −/− MEFs (RIKEN BRC) and HEK293 cells (ATCC) were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum (FBS; Sigma). HeLa (ATCC) and HepG2 (ATCC) cells were maintained in MEM (Invitrogen) supplemented with 10% FBS. Fibroblast cells, derived from Zellweger patients (GM13267 and GM13269), and control fibroblasts from patients with Ehlers-Danlos syndrome (GM15871 and GM13427) were obtained from Coriell Cell Repositories and cultured in MEM supplemented with 15% FBS (similar to what was reported previously for cells from individuals with ataxia telangectasia 19 , this phenotypic difference in ROS response was observed for multiple primary cultures of Zellweger and control fibroblasts, but was lost with prolonged culture of these untransformed cells in vitro (data not shown)). GFP-LC3 MCF-7 cells were provided by G. Mills (U.T. M.D. Anderson Cancer Center, USA). FAO cells (Sigma) were maintained in F12 media (Invitrogen) supplemented with 10% FBS and 2 mM l-glutamine (Invitrogen). All transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.
Plasmids and mutagenesis. The Flag-TSC2, Flag-TSC1 and Myc-TSC1 plasmids were described previously 24 . Plasmids DsRed-PST1 and EGFP-PTS1 were provided by M. Mancini (Baylor College of Medicine, USA). The DsRed-ARL was constructed by substituting the ARL sequence for a SKL PTS1 motif in the DsRed-PST1 construct. The plasmid mRFP-GFP-LC3 (ptfLC3) was purchased from Addgene. TSC2 mutant constructs were generated by site-directed mutagenesis using the Stratagene QuikChange Kit (Agilent Technologies) and validated by DNA sequencing.
Subcellular fractionation. Cytosolic, nuclear and membrane fractions were obtained as described previously 24 . Peroxisomes were isolated using Peroxisome Isolation Kit (Sigma) according to the manufacturer's protocol. Briefly, cells were homogenized in ice-cold peroxisome extraction buffer, and centrifuged twice at 1,000g for 10 min and then 2,000g for 10 min. The supernatant was collected, centrifuged at 25,000g for 20 min, and the pellet was re-suspended in the peroxisome extraction buffer that was subjected to density gradient centrifugation at 100,000g for 90 min. The peroxisome-enriched fraction was collected from the bottom layer of the density gradient (27.5% iodixanol).
Western analysis and immunoprecipitation assays. Cells were lysed in 1×
lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, and 2.5 mM sodium pyrophosphate) containing 1× complete protease inhibitor cocktail (Roche) and phosphatase inhibitor cocktails 1 and 2 (Sigma). For immunoprecipitations from HEK293 cell lysates, equal masses of protein were incubated with either Flag-IP beads (Sigma) or PEX 5 or PEX19 antibody and protein A agarose beads (Santa Cruz) overnight, washed, and loaded onto an SDS-PAGE gel for western blot analysis.
Immunofluorescence microscopy. Cells plated on coverslips were grown to 70% confluence, fixed with 4% paraformaldehyde for 15 min, permeabilized in 0.5% Triton X-100 for 10 min, and blocked with 3.75% BSA in PBS for 1 h, and incubated with primary antibodies (in blocking buffer) overnight at 4 • C. Secondary antibodies were applied for 1 h at 37 • C. Immunostaining of transfected cells was performed on glass chamber slides with staining 24 h post transfection. Staining procedures for GFP-LC3, RFP-GFP-LC3 and DsRed-ARL vesicles were as described above. Images (Z -stacks) were obtained with an LSM 710 Meta confocal system (Zeiss) and a Deltavision Deconvolution Microscope (Applied Precision). Identical exposure times were used for images used for direct comparisons. For co-localization analysis, Pearson's correlation coefficient was calculated using Imaris software V.7.6.1 (Bitplane AG). All of the co-localization calculations were performed on >40 cells from four independent experiments. The numbers of GFP-LC3, RFP-LC3 puncta or endogenous LC3-positive vesicles were calculated using Imaris software V.7.6.1 (Bitplane AG). At least 100 cells per condition in three independent experiments were used for quantification.
Functional assays. TSC2 GAP activity on Rheb was determined by the Rheb-GTP hydrolysis method as described previously 55 . Lysates for these analyses were obtained from HEK293 cells or TSC2 −/− MEFs co-transfected with Flag-TSC2 (WT or mutants RQ, RG, RW and RQ-9NT), Flag-TSC1, Myc-Rheb and HA-S6K for 24 h following transfection.
Protease protection assay. The crude peroxisomal fraction obtained by subcellular fractionation as outlined above was equally distributed to several tubes containing freshly prepared proteinase K (Roche) at a final concentration of 100 µg ml −1 . As a control, whole-cell extract in 1× lysis buffer was used to monitor protease digestion during the incubation period. Samples were then split into two groups, with and without 1% Triton X-100, and incubated on ice for 5, 15 and 30 min. Reactions were stopped by phenylmethylsulphonyl fluoride and immediately processed for western analysis.
Isolation of hippocampal neurons and polarity assays. Primary cultures of rodent hippocampal cells were prepared according to published protocols 56 . Briefly, E18 rat hippocampi were digested with papain for 10 min at 37 • C in Hank's balanced salt solution buffered with HEPES (Invitrogen). Cells were dissociated using neurobasal medium supplemented with B27 (Invitrogen), and immediately transfected with GFP and TSC constructs using the Amaxa Nucleofector system. Transfected neurons were plated on Lab-Tek II chambers slides (Nunc) coated with poly-d-lysine (1 mg ml −1 , Sigma) at a density of 1,000 cells per well. To determine polarity of neurons, 5 days after transfection, immunocytochemical staining was performing using the axonal marker Tau-1 (Chemicon). GFP-positive cells were categorized and quantified as no-axon, single-axon or multiple-axons as previously described 40 .
Transmission electron microscopy. FAO cells were cultured on 6-well dishes, and treated with vehicle (dimethylsulphoxide, DMSO) or 50 µM Wy-14643 (WY) for 24, 48 and 72 h, and fixed with electron microscopy buffer (2% paraformaldehyde and 3% glutaraldehyde in 0.1 M cacodylate buffer). The samples were prepared for microscopy by the High Resolution Electron Microscopy Facility at U.T. M.D. Anderson Cancer Center. Images were obtained using a transmission electron microscope at 80 kV, with ×25,000 magnification. Supplementary Fig. S6 . Supplementary Fig. S6 . Source data of statistical analysis are shown in Supplementary Table S1 . Representative western analysis using cell extracts from human fibroblasts obtained from a Zellweger patient (GM13269) or control fibroblasts (GM13427) treated with amino acid free media for 60 min, and stimulated with amino acid containing media for 10 min. mTORC1 signaling was monitored using anti-pS6K (T389), S6K, pS6 (S235/236), S6, p4EBP1(T37/46) and 4EBP1. Uncropped images of western blots are shown in Supplementary Fig. S6 . Source data of statistical analysis are shown in Supplementary Table S1 . and Flag-TSC2 mutants (RQ, RG and RW) stained with Flag (green) and LAMP1 (marker for lysosome, red). As a control, the cells were stained by anti-mTOR (green) and anti-LAMP1 (red). (Scale bar -10μm). (c) Representative images using HeLa cells transfected with Myc-TSC1 and Flag-TSC2 mutant (RQ) stained with Flag (red) and either calnexin (marker for endoplasmic reticulum, green) or VDAC (marker for mitochondria, green). (Scale bar -10μm). (d) HEK 293 cells were transfected with Myc-TSC1 and Flag-TSC2 wild type (WT) or the Flag-TSC2 mutants (RQ, RG, RW) or Flag-TSC2 L1624P (GAP mutant) or Flag-TSC2 G294E (TSC1 binding mutant). The lysates were immunoprecipitated using anti-Myc and control IgG, and samples were analyzed using anti-Flag and anti-myc antibodies. (e) Functional assays were performed using HEK 293 cells expressing Flag-TSC1, myc-Rheb, and Flag-TSC2 wild type (WT) or Flag-TSC2 mutant (RQ). mTOR signaling was monitored by measuring the ratio of pS6K (T389) to S6K level. Graph represents densitometric quantitation of the ratio of phospho-S6K to total S6K (±s.e.m., n = 3 independent experiments). *p < 0.05, ** p < 0.01. Uncropped images of western blots are shown in Supplementary Fig. S6 . Source data of statistical analysis are shown in Supplementary Table S1 . Catalase S1c S1c S1c S1c S1c S1c S1c S1c S1c S1d S1d S1d S1d S1d S1d S1d S1d S1d S1d 
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